A Phase Ib/IIa Study of INT-210 Capsules in Participants With Active Ulcerative Colitis

Clinical trial NCT07692165 · RECRUITING

Trial details

NCT number: NCT07692165
Sponsor: Innatus Therapeutics (Shanghai) Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Ulcerative Colitis (UC)

Start date: 2026-06-11
Primary completion: 2028-06-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.